The latest closing stock price for Trevi Therapeutics as of February 21, 2025 is 4.60.
An investor who bought $1,000 worth of Trevi Therapeutics stock at the IPO in 2019 would have $-417 today, roughly 0 times their original investment - a -8.60% compound annual growth rate over 6 years.
The all-time high Trevi Therapeutics stock closing price was 10.12 on June 03, 2019.
The Trevi Therapeutics 52-week high stock price is 5.05, which is 9.8% above the current share price.
The Trevi Therapeutics 52-week low stock price is 2.30, which is 50% below the current share price.
The average Trevi Therapeutics stock price for the last 52 weeks is 3.15.
An investor who bought $1,000 worth of Trevi Therapeutics stock at the IPO in 2019 would have $-417 today, roughly 0 times their original investment - a -8.60% compound annual growth rate over 6 years.
The all-time high Trevi Therapeutics stock closing price was 10.12 on June 03, 2019.
The Trevi Therapeutics 52-week high stock price is 5.05, which is 9.8% above the current share price.
The Trevi Therapeutics 52-week low stock price is 2.30, which is 50% below the current share price.
The average Trevi Therapeutics stock price for the last 52 weeks is 3.15.